{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T23:18:13Z","timestamp":1692055093849},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T00:00:00Z","timestamp":1425081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s40262-015-0245-7","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T07:00:52Z","timestamp":1425020452000},"page":"875-883","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Population Pharmacokinetic Modeling of Guanfacine in Pediatric Patients"],"prefix":"10.1007","volume":"54","author":[{"given":"William","family":"Knebel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ermer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc R.","family":"Gastonguay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,28]]},"reference":[{"key":"245_CR1","unstructured":"National Institute of Mental Health. Attention deficit hyperactivity disorder (ADHD). US Department of Health and Human Services; 2008."},{"issue":"9481","key":"245_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(05)66915-2","volume":"366","author":"J Biederman","year":"2005","unstructured":"Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366(9481):237\u201348.","journal-title":"Lancet."},{"issue":"25","key":"245_CR3","first-page":"915","volume":"2","author":"C Kratochvil","year":"2002","unstructured":"Kratochvil C. New ADHD treatment options on the horizon. Adv Stud Med. 2002;2(25):915\u20138.","journal-title":"Adv Stud Med."},{"issue":"7","key":"245_CR4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","volume":"158","author":"L Scahill","year":"2001","unstructured":"Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158(7):1067\u201374.","journal-title":"Am J Psychiatry."},{"issue":"8","key":"245_CR5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/00004583-199608000-00008","volume":"35","author":"DP Cantwell","year":"1996","unstructured":"Cantwell DP. Attention deficit disorder: a review of the past 10\u00a0years. J Am Acad Child Adolesc Psychiatry. 1996;35(8):978\u201387.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"245_CR6","unstructured":"INTUNIV\u00ae (guanfacine) extended-release tablets [package insert]. Wayne, PA: Shire Pharmaceuticals LLC."},{"issue":"9","key":"245_CR7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1592\/phco.27.9.1253","volume":"27","author":"SW Boellner","year":"2007","unstructured":"Boellner SW, Pennick M, Fiske K, Lyne A, Shojaei A. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder. Pharmacotherapy. 2007;27(9):1253\u201362.","journal-title":"Pharmacotherapy."},{"issue":"Suppl 1","key":"245_CR8","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1111\/j.1365-2125.1980.tb04901.x","volume":"10","author":"JR Kiechel","year":"1980","unstructured":"Kiechel JR. Pharmacokinetics and metabolism of guanfacine in man: a review. Br J Clin Pharmacol. 1980;10(Suppl 1):25S\u201332S.","journal-title":"Br J Clin Pharmacol."},{"issue":"10","key":"245_CR9","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/j.1552-4604.1987.tb02993.x","volume":"27","author":"SH Carchman","year":"1987","unstructured":"Carchman SH, Crowe JT Jr, Wright GJ. The bioavailability and pharmacokinetics of guanfacine after oral and intravenous administration to healthy volunteers. J Clin Pharmacol. 1987;27(10):762\u20137.","journal-title":"J Clin Pharmacol."},{"issue":"2","key":"245_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/cap.2010.0064","volume":"21","author":"SH Kollins","year":"2011","unstructured":"Kollins SH, Lopez FA, Vince BD, et al. Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011;21(2):111\u201320.","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"245_CR11","volume-title":"NONMEM Users Guide: Part I\u2013VII, (1989\u20132006)","author":"SL Beal","year":"2006","unstructured":"Beal SL, Sheiner LB, Boeckmann AJ. NONMEM Users Guide: Part I\u2013VII, (1989\u20132006). Ellicott City, MD: Icon Development Solutions; 2006."},{"issue":"2","key":"245_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2125.2000.00231.x","volume":"50","author":"BJ Anderson","year":"2000","unstructured":"Anderson BJ, Woollard GA, Holford NH. A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Br J Clin Pharmacol. 2000;50(2):125\u201334.","journal-title":"Br J Clin Pharmacol."},{"issue":"3","key":"245_CR13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2125.1998.00780.x","volume":"46","author":"BJ Anderson","year":"1998","unstructured":"Anderson BJ, Holford NH, Woollard GA, Chan PL. Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol. 1998;46(3):237\u201343.","journal-title":"Br J Clin Pharmacol."},{"issue":"5","key":"245_CR14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003088-199733050-00001","volume":"33","author":"BJ Anderson","year":"1997","unstructured":"Anderson BJ, McKee AD, Holford NH. Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clin Pharmacokinet. 1997;33(5):313\u201327.","journal-title":"Clin Pharmacokinet."},{"issue":"5","key":"245_CR15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-199630050-00001","volume":"30","author":"NH Holford","year":"1996","unstructured":"Holford NH. A size standard for pharmacokinetics. Clin Pharmacokinet. 1996;30(5):329\u201332.","journal-title":"Clin Pharmacokinet."},{"issue":"426","key":"245_CR16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/01621459.1994.10476768","volume":"89","author":"B Efron","year":"1994","unstructured":"Efron B. Missing data, imputation, and the bootstrap. J Am Stat Assoc. 1994;89(426):463\u201379.","journal-title":"J Am Stat Assoc."},{"issue":"1","key":"245_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0169-2607(98)00098-4","volume":"59","author":"J Parke","year":"1999","unstructured":"Parke J, Holford NH, Charles BG. A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Programs Biomed. 1999;59(1):19\u201329.","journal-title":"Comput Methods Programs Biomed."},{"issue":"3","key":"245_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF03190460","volume":"27","author":"EI Ette","year":"2002","unstructured":"Ette EI, Onyiah LC. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization. Eur J Drug Metab Pharmacokinet. 2002;27(3):213\u201324.","journal-title":"Eur J Drug Metab Pharmacokinet."},{"issue":"2","key":"245_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1011555016423","volume":"28","author":"Y Yano","year":"2001","unstructured":"Yano Y, Beal SL, Sheiner LB. Evaluating pharmacokinetic\/pharmacodynamic models using the posterior predictive check. J Pharmacokinet Pharmacodyn. 2001;28(2):171\u201392.","journal-title":"J Pharmacokinet Pharmacodyn."},{"issue":"4","key":"245_CR20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.clinthera.2007.04.016","volume":"29","author":"D Swearingen","year":"2007","unstructured":"Swearingen D, Pennick M, Shojaei A, Lyne A, Fiske K. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults. Clin Ther. 2007;29(4):617\u201325.","journal-title":"Clin Ther."},{"issue":"5","key":"245_CR21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2125.2006.02622.x","volume":"61","author":"I Mahmood","year":"2006","unstructured":"Mahmood I. Prediction of drug clearance in children from adults: a comparison of several allometric methods. Br J Clin Pharmacol. 2006;61(5):545\u201357.","journal-title":"Br J Clin Pharmacol."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-015-0245-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-015-0245-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-015-0245-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:41:09Z","timestamp":1559490069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-015-0245-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,28]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["245"],"URL":"https:\/\/doi.org\/10.1007\/s40262-015-0245-7","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,28]]}}}